Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-01 Sale | 2024-04-02 4:06 pm | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 4,000 | $58.66 | $234,640 | 407,473 (Indirect Direct) | View |
| 2024-03-01 Sale | 2024-03-05 4:04 pm | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 6,000 | $63.22 | $379,340 | 411,473 (Indirect Direct) | View |
| 2024-02-12 Sale | 2024-02-13 4:59 pm | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 1,431 | $67.77 | $96,974 | 149,570 (Indirect Direct) | View |
| 2024-01-29 Sale | 2024-01-31 4:34 pm | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 906 | $64.14 | $58,109 | 151,001 (Indirect Direct) | View |
| 2024-01-22 Sale | 2024-01-23 6:13 pm | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 3,551 | $65 | $230,801 | 151,907 (Indirect Direct) | View |
| 2024-01-16 Sale | 2024-01-17 4:36 pm | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 2,235 | $66.81 | $149,317 | 189,991 (Indirect Direct) | View |
| 2023-11-30 Sale | 2023-12-01 4:11 pm | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 14,158 | $54.73 | $774,884 | 401,848 (Indirect Direct) | View |
| 2023-07-03 Sale | 2023-07-06 4:16 pm | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 6,779 | $89.97 | $609,928 | 416,006 (Indirect Direct) | View |
| 2023-06-05 Sale | 2023-06-06 4:59 pm | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 69,779 | $88.8 | $6,196,527 | 422,785 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-18 Gift | 2024-04-19 7:27 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 14,164 | $0 | 149,570 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-02 4:06 pm | N/A 2027-10-18 | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 4,000 | $0 | 407,473 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-02 4:06 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 4,000 | $10.03 | 407,473 (Direct) | View |
| 2024-03-01 Exercise | 2024-03-05 4:04 pm | N/A 2027-10-18 | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 6,000 | $0 | 411,473 (Direct) | View |
| 2024-03-01 Exercise | 2024-03-05 4:04 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 6,000 | $10.03 | 411,473 (Direct) | View |
| 2024-01-16 Option Award | 2024-01-17 4:36 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 23,748 | $0 | 189,991 (Direct) | View |
| 2024-01-16 Option Award | 2024-01-17 4:36 pm | N/A 2034-01-15 | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 34,533 | $66.3 | 189,991 (Direct) | View |
| 2023-11-30 Exercise | 2023-12-01 4:11 pm | N/A 2027-10-18 | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 14,158 | $0 | 401,848 (Direct) | View |
| 2023-11-30 Exercise | 2023-12-01 4:11 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 14,158 | $10.03 | 401,848 (Direct) | View |
| 2023-07-03 Exercise | 2023-07-06 4:16 pm | N/A 2027-10-18 | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 6,779 | $0 | 416,006 (Direct) | View |
| 2023-07-03 Exercise | 2023-07-06 4:16 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 6,779 | $10.03 | 416,006 (Direct) | View |
| 2023-06-05 Exercise | 2023-06-06 4:59 pm | N/A 2027-10-18 | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 69,779 | $0 | 422,785 (Direct) | View |
| 2023-06-05 Exercise | 2023-06-06 4:59 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 69,779 | $10.03 | 422,785 (Direct) | View |
| 2023-05-03 Gift | 2023-05-03 4:22 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 20,000 | $0 | 133,945 (Direct) | View |
| 2023-04-19 Gift | 2023-04-20 4:15 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 36,232 | $0 | 133,945 (Direct) | View |
| 2023-02-21 Option Award | 2023-02-22 06:42 am | N/A 2032-01-20 | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 28,255 | $0 | 150,517 (Direct) | View |
| 2023-02-21 Tax Withholding | 2023-02-22 06:42 am | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 974 | $58.5 | 150,517 (Direct) | View |
| 2023-02-10 Tax Withholding | 2023-02-14 4:59 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 975 | $51.21 | 123,236 (Direct) | View |
| 2023-01-27 Tax Withholding | 2023-01-30 5:05 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 551 | $52.77 | 124,211 (Direct) | View |
| 2023-01-20 Tax Withholding | 2023-01-24 5:23 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 2,379 | $52.05 | 124,762 (Direct) | View |
| 2023-01-12 Option Award | 2023-01-17 8:00 pm | N/A 2033-01-11 | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 43,183 | $52.66 | 174,074 (Direct) | View |
| 2023-01-12 Option Award | 2023-01-17 8:00 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 27,488 | $0 | 174,074 (Direct) | View |
| 2022-04-25 Other | 2023-01-17 8:00 pm | N/A 2031-01-27 | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 26,250 | $0 | 174,074 (Direct) | View |
| 2022-02-10 Tax Withholding | 2022-02-14 4:17 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 875 | $47.12 | 103,403 (Direct) | View |
| 2022-01-28 Tax Withholding | 2022-02-01 6:05 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 650 | $38.59 | 104,278 (Direct) | View |
| 2022-01-21 Option Award | 2022-01-25 4:57 pm | N/A 2032-01-20 | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 74,457 | $0 | 148,598 (Direct) | View |
| 2021-06-08 Exercise | 2021-06-09 4:06 pm | N/A 2027-10-19 | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 39,880 | $0 | 432,760 (Direct) | View |
| 2021-06-08 Exercise | 2021-06-09 4:06 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 39,880 | $10.03 | 432,760 (Direct) | View |
| 2021-02-10 Tax Withholding | 2021-02-11 4:16 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 858 | $47.72 | 34,261 (Direct) | View |
| 2021-01-28 Option Award | 2021-02-01 4:42 pm | N/A 2031-01-27 | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 78,750 | $0 | 102,619 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-12 5:09 pm | N/A 2030-02-09 | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 81,813 | $0 | 93,512 (Direct) | View |